AKT1 and gastric cancer: In this sense, Zhao et al. [91] in their in vivo and in vitro investigations examined the anti-cancer effect of stigmasterol by inhibiting Akt/mTOR pathway in human gastric cancer cell lines SGC-7901 and MGC-803.